Ireland· IE-PA-PA2113/002/003
ACTAIR 300 IR sublingual tablets
A hausstaubmilben product containing dermatophagoides pteronyssinus extract + dermatophagoides farinae extract, registered in Ireland by Stallergenes. The same ATC class is registered in 11 of our 19 countries.
Checked against HPRA (Ireland) on
Informational only — not a medical device.
Where it is registered
Hausstaubmilben is registered in 11 of 19 countries.
Countries holding a registration under ATC V01AA03 (hausstaubmilben), each read from that country’s own register.
- This record: Ireland, from HPRA (Ireland)
- 6 of them publish a price we can compare per daily dose
Hausstaubmilben · ATC V01AA03
11 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
HPRA (Ireland)- Active substance
- Dermatophagoides Pteronyssinus Extract + Dermatophagoides Farinae Extract
- Manufacturer
- Stallergenes
- Country
- Ireland (IE)
- ATC code
- V01AA03
- ATC class
- Hausstaubmilben
- Reimbursed
- Not published by this register
- Source register
- HPRA (Ireland)
- Last checked
- September 28, 2026
Packs & prices · 1
- ie_pa_numberPA2113/002/003
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Hausstaubmilben in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- SwedenAcarizax 12 SQ-HDM Frystorkad sublingual tablettMedartuum AB
- United StatesOdactraALK-Abello A S
- NorwayAcarizaxALK-Abelló AS
- SpainACARIZAX 12 SQ-HDM LIOFILIZADO SUBLINGUALAlk-Abello A/S
- GermanyAcarizaxAlk-Abello A/S
- CanadaACARIZAXALK-ABELLO A/S
- FinlandAcarizaxALK-Abello A/S
- IcelandSoluprick SQ (House Dust Mites)ALK-Abelló A/S
Authorised across Europe · EMA
The same active substance is authorised in 22 EEA countries. Names it is sold under:
- Austria · Acarizax, Actair
- Belgium · Acarizax, Orylmyte
- Bulgaria · Актаир, Алиостал Прик, Алергенен Екстракт От Микрокърлежи
- Czechia · Acarizax, Actair
- Germany · Acarizax, Aitaro
- Denmark · Acarizax, Aitmyte
- Spain · Acarizax, Actair
- Finland · Acarizax
- France · Acarizax, Dusetlis
- United Kingdom (Northern Ireland) · Acarizax, Actair
- Croatia · Acarizax, Orylmyte
- Hungary · Acarizax, Staloral
- Italy · Accarizax, Orylmyte
- Luxembourg · Acarizax, Orylmyte
- Netherlands · Acarizax, Actair
- Norway · Acarizax, Aitmyte
- Poland · Acarizax, Actair
- Portugal · Actair
- Romania · Acarizax, Actair
- Sweden · Acarizax, Aitmyte
- Slovenia · Acarizax, Actair
- Slovakia · Acarizax, Actair
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of HPRA (Ireland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/866a2840-0ca5-4371-83c5-5a6c3aabb615 GET /v1/drugs/866a2840-0ca5-4371-83c5-5a6c3aabb615?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Sublingual tablet",
"routes": [
"Sublingual use"
],
"source": "hpra",
"atc_all": [
"V01AA03"
],
"strength": null,
"pa_number": "PA2113/002/003",
"substances": [
"Dermatophagoides Pteronyssinus Extract",
"Dermatophagoides Farinae Extract"
],
"legal_basis": "Hybrid application - change in withdrawal period (Article 19(1)(a) of Regulation (EU) 2019/6)",
"market_info": "Marketed",
"authorised_at": "08/10/2021",
"dispensing_status": "Product subject to prescription which may be renewed (B)",
"registration_status": "AU",
"supply_legal_status": "Supply through pharmacies only",
"interchangeable_code": null
}See everything about hausstaubmilben.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.